Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Hua Huang

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
International Journal of Surgical Pathology|May 12, 2012
CD25 is a novel marker of hepatic bile canaliculusZhong-Hua Lu, Wei -Chen, Chao-Xia Ju, et al.
Journal of Gastroenterology and Hepatology|June 3, 2009
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patientsYue Han, Li Hua Huang, Chuan Miao Liu, et al.
Molecular Cancer Therapeutics|March 8, 2017
The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and TumorsHui Zhang, Atish Patel, Yi-Jun Wang, et al.
Chinese Medical Journal|November 2, 2011
Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinomaXue-Song Li, Xiang Wu, Peng-Ju Zhao, et al.
Bioengineered|December 13, 2021
microRNA-378b regulates ethanol-induced hepatic steatosis by targeting CaMKK2 to mediate lipid metabolismYing-Zhao Wang, Jun Lu, Yuan-Yuan Li, et al.
Acta Pharmacologica Sinica|February 21, 2017
Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinomaXiao-Bin Guo, Wan-le Ma, Li-Juan Liu, et al.
Chinese Medical Journal|August 9, 2013
Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-upCui-jian Zhang, Peng-ju Zhao, Xue-song Li, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injuryJin Gu, Shen-Jie Tang, Shou-Yong Tan, et al.
Journal of Natural Products|March 15, 2022
Selaginellin Inhibits Melanogenesis via the MAPK Signaling PathwayYing Zhou, Hong-Liang Zeng, Xin-Yue Wen, et al.
Blood Transfusion = Trasfusione Del Sangue|February 13, 2013
An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese populationQing-Ping Wang, Guang-Tao Dong, Xue-Dong Wang, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
International Journal of Surgical Pathology|May 12, 2012
CD25 is a novel marker of hepatic bile canaliculusZhong-Hua Lu, Wei -Chen, Chao-Xia Ju, et al.
Journal of Gastroenterology and Hepatology|June 3, 2009
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patientsYue Han, Li Hua Huang, Chuan Miao Liu, et al.
Molecular Cancer Therapeutics|March 8, 2017
The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and TumorsHui Zhang, Atish Patel, Yi-Jun Wang, et al.
Chinese Medical Journal|November 2, 2011
Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinomaXue-Song Li, Xiang Wu, Peng-Ju Zhao, et al.
Bioengineered|December 13, 2021
microRNA-378b regulates ethanol-induced hepatic steatosis by targeting CaMKK2 to mediate lipid metabolismYing-Zhao Wang, Jun Lu, Yuan-Yuan Li, et al.
Acta Pharmacologica Sinica|February 21, 2017
Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinomaXiao-Bin Guo, Wan-le Ma, Li-Juan Liu, et al.
Chinese Medical Journal|August 9, 2013
Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-upCui-jian Zhang, Peng-ju Zhao, Xue-song Li, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injuryJin Gu, Shen-Jie Tang, Shou-Yong Tan, et al.
Journal of Natural Products|March 15, 2022
Selaginellin Inhibits Melanogenesis via the MAPK Signaling PathwayYing Zhou, Hong-Liang Zeng, Xin-Yue Wen, et al.
Blood Transfusion = Trasfusione Del Sangue|February 13, 2013
An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese populationQing-Ping Wang, Guang-Tao Dong, Xue-Dong Wang, et al.
Pageof 18